Orchid Pharma fundamental analysis

ORCHPHARMA

498.95

9.60 (-1.89%)
Last updated on 9 Mar, 2026 | 15:50 IST
Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Orchid Pharma Fundamentals

P/E Ratio

136.75

P/B Ratio

2.04

Div. Yield

0

Sector P/E

61.21

Sector P/B

2.64

Sec. Div. Yield

0.58

Orchid Pharma Fundamentals is currently trading with a P/E Ratio of 136.75, compared to the sector average of 61.21. Its P/B Ratio stands at 2.04, while the sector’s is 2.64. In terms of returns, the stock offers a Dividend Yield of 0%, which is than the sector’s 0.58%.

Orchid Pharma Score Card

  • price_icon
    Price

    Expensive

  • chart_icon
    Growth

    Good

  • quality_check
    Quality

    Poor

  • quality_check
    Management

    Poor

On its scorecard, Orchid Pharma reflects: Price – Expensive, Growth – Good, Quality – Poor, and Management – Poor. Together, these indicators provide a structured view of the company’s fundamentals.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost